logo
Sign in

YECO Stock Price, Chart, Stats & News

EV Biologics, Inc.
Save

EV Biologics, Inc. (YECO) does not currently pay a dividend.

723
Market cap
–
Current P/E
–
Forward P/E

YECO chart

About

Health care
Sector
Biotechnology
Industry

EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its proprietary, versatile EV platform to engineer innovative vaccines, treatments, and potential cures. Beyond EVs, it also dedicates efforts to cultivating human mesenchymal and other stem cells, as well as various cell-derived products, to address the needs of the cosmetic and biopharmaceutical industries.

Similar securities

Based on sector and market capitalization

Report issue